Filed: 2/14/2024ACC: 0001214659-24-002851
π What this filing means
INVUS FINANCIAL ADVISORS, LLC filed this quarterly 13FβHR report disclosing 7 equity positions with a total reported market value of $127.78M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$127.78M
Total AUM (reported)
17.17M
Total Shares
Allocation by class
ORD SHS$59.25M46.4%
COM$46.26M36.2%
CL A$22.28M17.4%
Portfolio Concentration
Top 3$96.24M75.3%
4β10$31.55M24.7%
Top 3 weight
75.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 17.17M
Sole
Full voting authority
17.17M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:
Taboola.com Ltd
SOLEShares9.97M
TypeSH
Market value$43.17M
33.78%
Sole
9.97M
Shared
0.00
None
0.00
Arcus Biosciences Inc
SOLEShares1.61M
TypeSH
Market value$30.79M
24.10%
Sole
1.61M
Shared
0.00
None
0.00
Coupang Inc
SOLEShares1.38M
TypeSH
Market value$22.28M
17.43%
Sole
1.38M
Shared
0.00
None
0.00
IHS Holding Limited
SOLEShares2.36M
TypeSH
Market value$10.84M
8.49%
Sole
2.36M
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares1.01M
TypeSH
Market value$9.27M
7.25%
Sole
1.01M
Shared
0.00
None
0.00
IONQ Inc
SOLEShares500K
TypeSH
Market value$6.20M
4.85%
Sole
500K
Shared
0.00
None
0.00
Novocure Ltd
SOLEShares350.88K
TypeSH
Market value$5.24M
4.10%
Sole
350.88K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Taboola.com LtdSOLE | ORD SHS | 9.97M | SH | $43.17M 33.78% | 9.97M | 0.00 | 0.00 |
Arcus Biosciences IncSOLE | COM | 1.61M | SH | $30.79M 24.10% | 1.61M | 0.00 | 0.00 |
Coupang IncSOLE | CL A | 1.38M | SH | $22.28M 17.43% | 1.38M | 0.00 | 0.00 |
IHS Holding LimitedSOLE | ORD SHS | 2.36M | SH | $10.84M 8.49% | 2.36M | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | COM | 1.01M | SH | $9.27M 7.25% | 1.01M | 0.00 | 0.00 |
IONQ IncSOLE | COM | 500K | SH | $6.20M 4.85% | 500K | 0.00 | 0.00 |
Novocure LtdSOLE | ORD SHS | 350.88K | SH | $5.24M 4.10% | 350.88K | 0.00 | 0.00 |